Ufp Technologies (UFPT) Income from Continuing Operations (2010 - 2026)
Ufp Technologies' (UFPT) quarterly Income from Continuing Operations came in at 17495000.0 in Q1 2026, up 1.81% YoY from 17184000.0 in Q1 2025, and little changed on a QoQ basis from 17566000.0 in Q4 2025.
Ufp Technologies (UFPT) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Ufp Technologies (UFPT) has 17 years of Income from Continuing Operations data on file, last reported at 17495000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 1.81% year-over-year to 17495000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 68624000.0 (up 8.12% YoY) and the FY2025 annual result came in at 68313000.0, up 15.82% from the prior year.
- Income from Continuing Operations steadied at 17495000.0 in Q1 2026, from 17566000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 19540000.0 in Q3 2022 to a low of 4858000.0 in Q1 2022.
- A 5-year average of 13617764.71 and a median of 13552000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations surged 493.82% — and 2023, when it tumbled 40.15%.
- Tracing UFPT's Income from Continuing Operations over 5 years: stood at 8462000.0 in 2022, then jumped by 37.18% to 11608000.0 in 2023, then jumped by 41.07% to 16375000.0 in 2024, then increased by 7.27% to 17566000.0 in 2025, then dropped by 0.4% to 17495000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 17495000.0 (Q1 2026), 17566000.0 (Q4 2025), and 16383000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Ufp Technologies | 2.34 Bn | 2.33 Bn | 50.92 Mn | 20.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.85 Mn |
| Mar 31, 2026 | 17.50 Mn |
| Dec 31, 2025 | 17.57 Mn |
| Sep 30, 2025 | 16.38 Mn |
| Jun 30, 2025 | 17.18 Mn |
| Mar 31, 2025 | 17.18 Mn |
| Dec 31, 2024 | 16.38 Mn |
| Sep 30, 2024 | 16.36 Mn |
| Jun 30, 2024 | 13.55 Mn |
| Mar 31, 2024 | 12.69 Mn |
| Dec 31, 2023 | 11.61 Mn |
| Sep 30, 2023 | 11.69 Mn |
| Jun 30, 2023 | 11.88 Mn |
| Mar 31, 2023 | 9.74 Mn |
| Dec 31, 2022 | 8.46 Mn |
| Sep 30, 2022 | 19.54 Mn |
| Jun 30, 2022 | 8.93 Mn |
| Mar 31, 2022 | 4.86 Mn |
| Dec 31, 2021 | 1.43 Mn |
| Sep 30, 2021 | 3.79 Mn |